Satyavrat Shukla
Equibles does not estimate personal net worth.
About Satyavrat Shukla
Earlier roles on record: CFO at Alaunos Therapeutics, Inc. (TCRT) until December 31, 2020. The proxy statement of Alaunos Therapeutics, Inc. reports total compensation of $1,252,211 for Satyavrat Shukla in fiscal 2020, including a base salary of $410,000. Disclosed compensation is on record for 2 fiscal years. Satyavrat Shukla has spoken on 1 earnings call across 1 company, most recently for Alaunos Therapeutics, Inc. on May 7, 2020. The companies whose calls Satyavrat Shukla spoke on are classified in the Healthcare sector.
Satyavrat Shukla on recent calls
“So just to answer your question, as I understood it, for R&D, you saw that our spend for this quarter went up by about $2 million. R&D is our priority. So COVID notwithstanding, we would expect sort of a similar ramp to take place by the middle of the year.”
Affiliation history
-
Start not stated–2020-12-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Alaunos Therapeutics, Inc. (TCRT) | Former Chief Financial Officer | $410,000 | $1,252,211 |
| 2019 | Alaunos Therapeutics, Inc. (TCRT) | Former Chief Financial Officer | $174,500 | $1,822,218 |